Gaipa, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 9.169
AS - Asia 4.028
EU - Europa 3.420
SA - Sud America 563
Continente sconosciuto - Info sul continente non disponibili 479
AF - Africa 105
OC - Oceania 13
Totale 17.777
Nazione #
US - Stati Uniti d'America 8.753
SG - Singapore 1.484
CN - Cina 883
IT - Italia 870
HK - Hong Kong 497
DE - Germania 432
RU - Federazione Russa 427
VN - Vietnam 424
BR - Brasile 420
SE - Svezia 419
CA - Canada 333
IE - Irlanda 301
GB - Regno Unito 213
UA - Ucraina 176
FR - Francia 148
IN - India 143
BD - Bangladesh 136
FI - Finlandia 87
TR - Turchia 81
ID - Indonesia 68
ES - Italia 54
BE - Belgio 50
NL - Olanda 49
PL - Polonia 44
AR - Argentina 43
KR - Corea 40
IQ - Iraq 39
DK - Danimarca 37
MX - Messico 37
JP - Giappone 36
PK - Pakistan 34
PH - Filippine 33
ZA - Sudafrica 33
AT - Austria 28
CO - Colombia 24
EC - Ecuador 21
SA - Arabia Saudita 19
VE - Venezuela 16
CL - Cile 14
CH - Svizzera 12
UZ - Uzbekistan 12
AU - Australia 11
ET - Etiopia 11
EU - Europa 11
JO - Giordania 11
RO - Romania 11
JM - Giamaica 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
KE - Kenya 8
MA - Marocco 8
MY - Malesia 8
TH - Thailandia 8
GR - Grecia 7
IL - Israele 7
IR - Iran 7
LT - Lituania 7
NP - Nepal 7
PY - Paraguay 7
TW - Taiwan 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
NO - Norvegia 6
RS - Serbia 6
AL - Albania 5
CR - Costa Rica 5
GT - Guatemala 5
LK - Sri Lanka 5
NG - Nigeria 5
PE - Perù 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
HU - Ungheria 4
MU - Mauritius 4
NI - Nicaragua 4
SV - El Salvador 4
CI - Costa d'Avorio 3
DZ - Algeria 3
KG - Kirghizistan 3
LU - Lussemburgo 3
PA - Panama 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GH - Ghana 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
Totale 17.289
Città #
Ann Arbor 1.391
Singapore 856
Ashburn 838
San Jose 562
Hong Kong 469
Woodbridge 436
Chandler 382
Fairfield 371
Wilmington 352
Houston 305
Dublin 292
Milan 274
Frankfurt am Main 266
New York 214
Toronto 209
Jacksonville 178
Seattle 164
Los Angeles 160
Dearborn 150
Council Bluffs 142
Beijing 138
Santa Clara 127
Cambridge 122
Ho Chi Minh City 120
Chicago 115
Princeton 101
Dallas 91
Shanghai 81
The Dalles 81
Hanoi 75
Nanjing 66
Boardman 64
Buffalo 61
Hefei 59
Altamura 51
Rome 50
Lauterbourg 49
Brussels 46
Lawrence 46
Lissone 46
Jakarta 44
São Paulo 41
Phoenix 40
Helsinki 39
Warsaw 39
Atlanta 38
Denver 37
Munich 36
San Diego 36
Fremont 35
Moscow 35
Guangzhou 34
Orem 34
London 33
Seoul 32
Montreal 30
Dong Ket 29
Lachine 29
Brooklyn 27
Tokyo 27
Columbus 26
Hangzhou 26
Nanchang 23
Johannesburg 21
Vienna 21
Tianjin 19
Haiphong 18
Jinan 18
Kocaeli 18
Boston 17
Chennai 17
Da Nang 17
Dhaka 17
Rio de Janeiro 17
San Francisco 17
Shenyang 17
Andover 16
Nuremberg 16
Amsterdam 15
Ankara 15
Hebei 15
Poplar 15
Zhengzhou 15
Brasília 14
Salt Lake City 14
Turin 14
Mexico City 13
Mumbai 13
Ottawa 13
Pune 13
Stockholm 13
Figino 12
Belo Horizonte 11
Edmonton 11
Monza 11
Ningbo 11
Tashkent 11
Addis Ababa 10
Istanbul 10
Kent 10
Totale 10.915
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 510
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 489
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 489
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 469
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 463
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 457
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 443
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 432
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 432
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 430
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 430
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 405
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 405
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 400
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 379
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 364
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 363
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 354
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 353
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 348
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies 347
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 330
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 326
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 325
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 320
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice 317
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 312
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 309
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 307
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 293
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 289
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 285
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 284
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 277
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 273
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 270
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 266
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 265
Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling 264
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 262
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 259
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 256
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 246
Linking cell function with perfusion: Insights from the transcatheter delivery of bone marrow-derived CD133 + cells in ischemic refractory cardiomyopathy trial (RECARDIO) 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 246
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining 232
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 225
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 218
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 208
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 208
Noonan Syndrome Peripheral Blood Cells Show Enhanced Spontaneous Colonies Growth In Vitro and Hyperactive JAK and RAS Intracellular Signalling Pathways 205
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 205
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 201
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 200
Monitoring of minimal residual disease in leukemia, advantages and pitfalls 189
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 179
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 164
Totale 17.777
Categoria #
all - tutte 53.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022646 0 0 0 75 54 74 41 46 90 84 67 115
2022/20231.424 151 462 105 140 69 205 35 84 97 9 41 26
2023/2024934 29 29 48 49 131 239 180 32 51 26 18 102
2024/20252.032 98 187 88 99 179 90 88 84 270 325 194 330
2025/20266.307 707 274 425 712 797 341 968 250 521 525 351 436
2026/20271.373 224 459 564 126 0 0 0 0 0 0 0 0
Totale 17.777